| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/ARCHINTE.163.20.2527 |
| P698 | PubMed publication ID | 14609791 |
| P50 | author | Jeremy Sobel | Q125316026 |
| Patricia M Griffin | Q124220349 | ||
| Robert V. Tauxe | Q7350556 | ||
| P2093 | author name string | Mark E Beatty | |
| David A Ashford | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastrointestinal anthrax | Q18554504 |
| P304 | page(s) | 2527-2531 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Gastrointestinal anthrax: review of the literature | |
| P478 | volume | 163 |
| Q39634673 | A case of fatal gastrointestinal anthrax in north eastern iran. |
| Q26796601 | Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination |
| Q39167892 | Anthrax kills wild chimpanzees in a tropical rainforest |
| Q36112160 | Anthrax outbreaks in Bangladesh, 2009-2010. |
| Q37595764 | Anthrax undervalued zoonosis. |
| Q41991031 | Anthrax: Where Margins are Merging between Emerging Threats and Bioterrorism |
| Q27654239 | Cellular Functions and X-ray Structure of Anthrolysin O, a Cholesterol-dependent Cytolysin Secreted by Bacillus anthracis |
| Q42735019 | Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults |
| Q33779478 | Colonic immune suppression, barrier dysfunction, and dysbiosis by gastrointestinal bacillus anthracis Infection. |
| Q37294992 | Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples |
| Q35155908 | Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions |
| Q51779653 | Gastric pH and Toxin Factors Modulate Infectivity and Disease Progression After Gastrointestinal Exposure to Bacillus anthracis. |
| Q37128448 | Gastrointestinal anthrax: clinical experience in 5 cases |
| Q40506267 | Impact of Gastrointestinal Bacillus anthracis Infection on Hepatic B Cells |
| Q34107000 | In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli |
| Q42924668 | Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax |
| Q35155780 | New insights into gastrointestinal anthrax infection. |
| Q42634046 | Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice |
| Q26999364 | Particle size and pathogenicity in the respiratory tract |
| Q28392599 | Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax |
| Q28397091 | Pediatric anthrax clinical management |
| Q36235362 | Phage-based platforms for the clinical detection of human bacterial pathogens |
| Q90159942 | Potential distributions of Bacillus anthracis and Bacillus cereus biovar anthracis causing anthrax in Africa |
| Q33286415 | Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax |
| Q30203862 | Rapid Detection of Bacillus anthracis in Complex Food Matrices Using Phage-Mediated Bioluminescence |
| Q92746707 | Rapid Presumptive Identification of Bacillus anthracis Isolates Using the Tetracore RedLine Alert™ Test |
| Q47153422 | Scientific Opinion on the public health hazards to be covered by inspection of meat (solipeds) |
| Q38822566 | The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin |
| Q35688283 | The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection |
| Q30424243 | Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host |
Search more.